Diclofenac Sodium Solution

Diclofenac Sodium Solution

Diclofenac Sodium Solution Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

The refractive stability of patients undergoing corneal refractive procedures and treated with diclofenac sodium has not been established. Patients should be monitored for a year following use in this setting.

With some nonsteroidal anti-inflammatory drugs, there exists the potential for increased bleeding time due to interference with thrombocyte aggregation. There have been reports that ocularly applied nonsteroidal anti-inflammatory drugs can cause increased bleeding of ocular tissues (including hyphemas) in conjunction with ocular surgery.

There is the potential for cross-sensitivity to acetylsalicylic acid, phenylacetic acid derivatives, and other nonsteroidal anti-inflammatory agents. Therefore, caution should be used when treating individuals who have previously exhibited sensitivities to these drugs.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

Diclofenac sodium ophthalmic solution is indicated for the treatment of postoperative inflammation in patients who have undergone cataract extraction and for the temporary relief of pain and photophobia in patients undergoing corneal refractive surgery.

History

There is currently no drug history available for this drug.

Other Information

Diclofenac sodium ophthalmic solution, 0.1% is a sterile, topical, nonsteroidal, anti-inflammatory product for ophthalmic use. Diclofenac sodium is designated chemically as Benzeneacetic acid, 2-[(2,6-dichlorophenyl)amino] monosodium salt, with a molecular formula of C14H10Cl2NNaO2. The structural formula of diclofenac sodium is:

Image from Drug Label Content

Diclofenac sodium ophthalmic solution is available as a sterile solution which contains diclofenac sodium 0.1% (1 mg/mL).

Inactive Ingredients: Boric acid, edetate disodium, polyoxyl 35 castor oil, sorbic acid, tromethamine, and water for injection.

Diclofenac sodium is a white or slightly yellow crystalline powder.  It is freely soluble in methanol, soluble in alcohol, sparingly soluble in water, and slightly soluble in acetone. Its molecular weight is 318.1. Diclofenac sodium ophthalmic solution, 0.1% is an iso-osmotic solution with an osmolality between 270 mOsmols/kg and 310 mOsmols/kg, buffered at a pH between 6.0 to 8.0. Diclofenac sodium ophthalmic solution has a faint characteristic odor of castor oil.

Diclofenac Sodium Solution Manufacturers


  • Apotex Corp.
    Diclofenac Sodium Solution [Apotex Corp.]
  • Apotex Corp.
    Diclofenac Sodium Solution [Apotex Corp.]
  • Sandoz Inc
    Diclofenac Sodium Solution [Sandoz Inc]
  • Pharmaceutica North America, Inc
    Diclofenac Sodium Solution [Pharmaceutica North America, Inc]

Login To Your Free Account